Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,848,057 papers from all fields of science
Search
Sign In
Create Free Account
HspE7
Known as:
HPV 16 E7/HSP65 Vaccine
, Verpasep Caltespen
, BCG65-E7
Expand
A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Antigen Sensitization
Cytotoxic T-Lymphocytes
T-Cell Activation
immunopotentiation
Expand
Narrower (1)
SGN-00101
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.
K. Van Doorslaer
,
L. Reimers
,
Yevgeniy Y. Studentsov
,
M. Einstein
,
R. Burk
Gynecologic oncology
2010
Corpus ID: 25445140
Review
2008
Review
2008
Medical treatment of cervical intraepithelial neoplasia II, III: an update review
C. Kietpeerakool
,
J. Srisomboon
International Journal of Clinical Oncology
2008
Corpus ID: 33902451
Cervical intraepithelial neoplasia (CIN) II, III is a preinvasive stage of squamous cell carcinoma of the uterine cervix. The…
Expand
2007
2007
Induction of CD4-Independent E7-Specific CD8+ Memory Response by Heat Shock Fusion Protein
Hongwei Liu
,
B. Wu
,
G. Rowse
,
P. Emtage
Clinical and Vaccine Immunology
2007
Corpus ID: 24466656
ABSTRACT Infection with human papillomavirus type 16 (HPV16) is strongly associated with a number of disease states, of which…
Expand
2007
2007
Gateways to clinical trials.
M. Bayes
Methods and findings in experimental and clinical…
2007
Corpus ID: 25431539
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan…
Expand
2007
2007
Verpasep caltespen vaccine shows efficacy against cervical dysplasia
2007
Corpus ID: 195119436
Highly Cited
2005
Highly Cited
2005
HspE7 Treatment of Pediatric Recurrent Respiratory Papillomatosis: Final Results of an Open-Label Trial
C. Derkay
,
Richard J. H. Smith
,
+5 authors
J. Neefe
The Annals of otology, rhinology, and laryngology
2005
Corpus ID: 42379118
Objectives: We sought to evaluate the effectiveness of HspE7, a recombinant fusion protein of Hsp65 from Mycobacterium bovis BCG…
Expand
Review
2005
Review
2005
Technology evaluation: HspE7 (Stressgen).
P. Maciag
,
Y. Paterson
Current opinion in molecular therapeutics
2005
Corpus ID: 13357682
Stressgen is developing HspE7, a recombinant fusion protein comprising the human papillomavirus (HPV) E7 antigen and the heat…
Expand
Review
2002
Review
2002
Activity of HspE7, a Novel Immunotherapy, in Patients with Anogenital Warts
S. Goldstone
,
J. Palefsky
,
Mark T Winnett
,
J. Neefe
Diseases of the colon and rectum
2002
Corpus ID: 10591772
AbstractPURPOSE: Human papillomavirus causes anogenital squamous intraepithelial lesions, warts, and cancer. Treatment of…
Expand
2001
2001
Technology evaluation: HspE7, StressGen Biotechnologies Corp.
S. Hunt
Current opinion in molecular therapeutics
2001
Corpus ID: 40214286
StressGen is developing HspE7 (SGN-00101) as a potential therapy for human papillomavirus (HPV)-associated conditions. It is a…
Expand
2000
2000
Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7
N. R. Chu
,
H. Wu
,
T. Wu
,
L. Boux
,
L. Mizzen
,
M. Siegel
Cell stress & chaperones
2000
Corpus ID: 3051833
Abstract Human papillomavirus type 16 (HPV16) infection has been linked to the development of cervical and anal dysplasia and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE